183 related articles for article (PubMed ID: 38239236)
1. [Not Available].
Jiang P; Yao C; Guo DA
Acta Pharm Sin B; 2024 Jan; 14(1):38-66. PubMed ID: 38239236
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms.
Huang J; Zhang J; Sun C; Yang R; Sheng M; Hu J; Kai G; Han B
J Ethnopharmacol; 2024 Jan; 318(Pt B):117022. PubMed ID: 37572929
[TBL] [Abstract][Full Text] [Related]
3. Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation.
Zhao H; Liang Y; Sun C; Zhai Y; Li X; Jiang M; Yang R; Li X; Shu Q; Kai G; Han B
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499502
[TBL] [Abstract][Full Text] [Related]
4. Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target.
Chen J; Liu Q; He J; Li Y
Front Immunol; 2022; 13():958790. PubMed ID: 36045667
[TBL] [Abstract][Full Text] [Related]
5. Lupus nephritis: new progress in diagnosis and treatment.
Yu C; Li P; Dang X; Zhang X; Mao Y; Chen X
J Autoimmun; 2022 Oct; 132():102871. PubMed ID: 35999111
[TBL] [Abstract][Full Text] [Related]
6. New insights for regulatory T cell in lupus nephritis.
Li Y; Tang D; Yin L; Dai Y
Autoimmun Rev; 2022 Aug; 21(8):103134. PubMed ID: 35690245
[TBL] [Abstract][Full Text] [Related]
7. Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy.
Jiang S; Jiao Y; Zou G; Gao H; Zhuo L; Li W
Front Med (Lausanne); 2022; 9():845679. PubMed ID: 35479942
[TBL] [Abstract][Full Text] [Related]
8. Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis.
Wang YJ; Li YX; Li S; He W; Wang ZR; Zhan TP; Lv CY; Liu YP; Yang Y; Zeng XX
Biomed Pharmacother; 2022 May; 149():112799. PubMed ID: 35279011
[TBL] [Abstract][Full Text] [Related]
9. Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway.
Zhang Y; Li Z; Wu H; Wang J; Zhang S
J Ethnopharmacol; 2022 Apr; 288():115004. PubMed ID: 35051603
[TBL] [Abstract][Full Text] [Related]
10. Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis.
Krata N; Foroncewicz B; Zagożdżon R; Moszczuk B; Zielenkiewicz M; Pączek L; Mucha K
Arch Immunol Ther Exp (Warsz); 2021 Dec; 70(1):3. PubMed ID: 34914001
[TBL] [Abstract][Full Text] [Related]
11. Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway.
Pei S; Li Y
Clinics (Sao Paulo); 2021; 76():e2904. PubMed ID: 34909911
[TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese Medicine in Treating IgA Nephropathy: From Basic Science to Clinical Research.
Wang XH; Lang R; Liang Y; Zeng Q; Chen N; Yu RH
J Transl Int Med; 2021 Sep; 9(3):161-167. PubMed ID: 34900626
[TBL] [Abstract][Full Text] [Related]
13. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging.
Wang Z; Fu W; Huo M; He B; Liu Y; Tian L; Li W; Zhou Z; Wang B; Xia J; Chen Y; Wei J; Abliz Z
Acta Pharm Sin B; 2021 Nov; 11(11):3665-3677. PubMed ID: 34900545
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review.
Farooq H; Aemaz Ur Rehman M; Asmar A; Asif S; Mushtaq A; Qureshi MA
J Taibah Univ Med Sci; 2022 Feb; 17(1):1-13. PubMed ID: 34602936
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
17. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
Kant S; Kronbichler A; Sharma P; Geetha D
Am J Kidney Dis; 2022 Apr; 79(4):582-600. PubMed ID: 34508831
[TBL] [Abstract][Full Text] [Related]
18. An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective.
Huang X; Xu G
Front Pharmacol; 2021; 12():715253. PubMed ID: 34497518
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
